Head to Head Review: Milestone Scientific (MLSS) and The Competition

Milestone Scientific (NYSE:MLSS – Get Free Report) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its rivals? We will compare Milestone Scientific to similar companies based on the strength of its analyst recommendations, institutional ownership, risk, earnings, valuation, dividends and profitability.

Analyst Ratings

This is a breakdown of recent recommendations for Milestone Scientific and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Milestone Scientific 0 0 1 0 3.00
Milestone Scientific Competitors 4309 10596 18377 837 2.46

Milestone Scientific currently has a consensus price target of $1.00, indicating a potential upside of 225.73%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.32%. Given Milestone Scientific’s stronger consensus rating and higher possible upside, research analysts plainly believe Milestone Scientific is more favorable than its rivals.

Earnings and Valuation

This table compares Milestone Scientific and its rivals gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Milestone Scientific $9.42 million -$6.93 million -7.67
Milestone Scientific Competitors $1.89 billion $136.85 million 5.73

Milestone Scientific’s rivals have higher revenue and earnings than Milestone Scientific. Milestone Scientific is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Insider & Institutional Ownership

5.8% of Milestone Scientific shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 9.2% of Milestone Scientific shares are owned by insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Volatility & Risk

Milestone Scientific has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500. Comparatively, Milestone Scientific’s rivals have a beta of 5.41, suggesting that their average share price is 441% more volatile than the S&P 500.

Profitability

This table compares Milestone Scientific and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Milestone Scientific -52.01% -60.26% -40.23%
Milestone Scientific Competitors -300.62% -179.55% -22.71%

Summary

Milestone Scientific rivals beat Milestone Scientific on 8 of the 13 factors compared.

Milestone Scientific Company Profile

(Get Free Report)

Milestone Scientific develops and commercializes computer-controlled drug-delivery instruments for dental and medical applications. Its technology is designed to regulate the flow and pressure of injections, with the aim of improving control and reducing discomfort during procedures. In dentistry, the company offers systems including the STA Single Tooth Anesthesia System and CompuDent, which are used to deliver local anesthetic. Its medical products include the CompuFlo system, designed for applications such as epidural injections and other procedures involving controlled drug delivery.

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.